;

Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Finance > Staar Surgical adjourns vote on acquisition by Alcon

Finance

Staar Surgical adjourns vote on acquisition by Alcon

Published by Global Banking and Finance Review

Posted on October 23, 2025

Featured image for article about Finance

(Reuters) -Staar Surgical has adjourned its shareholder vote on Swiss eyecare giant Alcon's $1.5 billion takeover offer until November 6, the company said on Thursday.

The delay comes amid opposing campaigns between Staar's board and key investors, led by Broadwood Partners which owns 27.5%. Opposing shareholders argue that the deal undervalues the business and reflects a flawed sale process.

(Reporting by Maria Rugamer; Editing by Matt Scuffham)

More from Finance

Explore more articles in the Finance category

Volkswagen welcomes EU move to drop combustion engine ban

Incoming Kraft Heinz CEO says he reserves right to improve split

FCAS fighter jet "very unlikely" after ministers' talks, source says

Campari's parent company settles tax dispute with 405 million euro payment

Universal offers to sell Downtown's Curve to win EU approval, source says

Auto sector divided as EU unveils plans to undo 2035 combustion engine ban

Italy's offshore wind push languishes, putting climate goals at risk

New Rome metro stations showcase ancient treasures after years of delays

Exclusive-California Pizza Kitchen reaches buyout deal, names new leadership

Greeks protest against low wages ahead of 2026 budget vote

AI boom seen lifting chipmaking equipment sales 9% to $126 billion in 2026

New Czech government signals tough stance on migration, EU emissions rules

View All Finance Posts